Materials and Carriers Development for Glucose-Responsive Insulin

Abstract

Metrics & MoreArticle Recommendations CONSPECTUS: Insulin replacement therapy is an essential and effective treatment strategy for controlling the blood glucose level (BGL) of people without sufficient endogenous insulin production. However, insulin therapy faces challenges such as daily multiple injections and hypoglycemia risk arising from its narrow therapeutic index, which together leads to poor BGL control. Thus, glucose-responsive insulin delivery systems that can mimic β-cell function are developed to improve BGL control and reduce injection frequency. Glucose-responsive materials-based insulin delivery systems are competent in tightly controlling the BGL with an additional benefit of reducing the hypoglycemia risk. Glucose-responsive materials generally work together with three major glucose-sensing elements: glucose oxidase (GOx), phenylboronic acid (PBA), and glucose-binding molecules. Based on glucose-sensing elements, glucose-responsive materials are rationally designed to sense the change in glucose concentration or indirect signals associated with glucose fluctuation, such as pH, H 2 O 2 concentration, and O 2 level, and adjust their physical or chemical characteristics accordingly.Many advanced glucose-responsive materials have been developed along this line, aiming to achieve robust glucose-responsive insulin release performance and elevate their therapeutic outcome. These advanced materials mainly include organic materials such as biomacromolecules, synthetic polymers, polypeptides, liposomes, and inorganic materials such as calcium phosphate (Ca 3 (PO 4 ) 2 ) and metal organic frameworks (MOFs). Built on these glucose-responsive materials, other groups and we have developed various carriers such as hydrogels, micro/nanoparticles, liposomes, complexes, cell−drug conjugates, and microneedle (MN) array patches. These delivery systems can release insulin via glucose-stimulated swelling/contraction, dissolution, pore size change, charge reversal, and polymer deterioration. Also, these carriers are continuously under development to accelerate responsive rate, increase response index, and improve biocompatibility. Our group focuses on the synthesis of glucoseresponsive materials and the design of glucose-responsive MN array patches, hydrogels, insulin complexes, and cell−drug conjugates for the treatment of diabetes in a dose-, spatial-, and temporal-controlled fashion. These closed-loop insulin delivery systems can respond to BGL alternation and secrete the correct amount of insulin accordingly. Also, MN array patches have the additional merits of reducing pain and easy administration.In this Account, we briefly introduce the glucose-responsive mechanisms and the relevant requirements of materials that can work cooperatively with these mechanisms. Then, we highlight our group's work in preparing various materials for constructing glucoseresponsive carriers. We are mainly aiming to improve glucose-responsive properties, administration feasibility, and in vivo biocompatibility. The challenges and perspe...

Schottky Junction Nanozyme Based on Mn-Bridged Co-Phthalocyanines and Ti3C2Tx Nanosheets Boosts Integrative Type I and II Photosensitization for Multimodal Cancer Therapy

“…The CoPc-Mn complex and Ti 3 C 2 T x NSs were assembled through π–π stacking and hydrogen bonding, , creating a Schottky junction due to their ultrathin NS-like structure. Further, PEG was used to modify CoPc-Mn/Ti 3 C 2 T x (represented as CoPc-Mn/Ti 3 C 2 T x -PEG) to enhance water solubility and biocompatibility . This Schottky junction substantially enhanced electron–hole separation and exhibited potent redox potential for self-supplying H 2 O 2 and O 2 .…”

“…Further, PEG was used to modify CoPc-Mn/Ti 3 C 2 T x (represented as CoPc-Mn/Ti 3 C 2 T x -PEG) to enhance water solubility and biocompatibility. 50 This Schottky junction substantially enhanced electron−hole separation and exhibited potent redox potential for self-supplying H 2 O 2 and O 2 . Benefiting from the superior photocatalytic abilities of the two components, the proposed CoPc-Mn/Ti 3 C 2 T x -PEG Schottky junction not only showed substantially high photothermal performance under NIR light irradiation and outstanding photoacoustic imaging (PAI) capability, but also exhibited synergistic type I PDT and type II PDT performance, resulting in the production of •O 2 − , H 2 O 2 , and •OH through electron transfer and the generation of 1 O 2 through energy transfer.…”

Hydrogels as promising platforms for engineered living bacteria-mediated therapeutic systems

“…In particular, hydrogels have drawn much attention as potential platforms in the field of drug delivery, because they can not only control the release of various therapeutics in a spatial and temporal manner but also offer a simple administration method for complicated drug regimens [ [23] , [24] , [25] , [26] , [27] , [28] ]. Furthermore, hydrogels have presented many unique advantages for bioactive therapeutic delivery [ 29 ]. For example, these materials have good biocompatibility, tunable chemical permeability, and excellent mechanical compliance that is similar to the extracellular matrix and beneficial to maintaining the biomedical activities of bioactive therapeutics [ 15 , 30 ].…”

Recent Advances in Oral and Transdermal Protein Delivery Systems

“…PBA has the equilibrium between the uncharged and anionically charged forms, and it could bind with 1,2‐ or 1,3‐cis‐diols to shift the equilibrium to the negatively charged forms [160] . Based on this concept, several PBA‐based systems were developed for on‐demand insulin delivery [152a, 161] . Yu et al.…”

“…In addition to local hypoxia, researchers have taken advantage of enzymatically generated local H 2 O 2 for self-regulated insulin delivery. [152] Hu et al integrated H 2 O 2 -responsive polymeric vesicles loaded with GOx and insulin with a MN patch to achieve controlled insulin delivery (Figure 16b). [153] Local acidification by the above enzymatic reaction can also act as a trigger to promote protein release from the MNs.…”